Do you mean like genetic? Or progressive?Sorry if this has been answered before, this is quite a large thread, but has anything been said about this being effective for congenital sensorineural hearing loss?
Possibly not. The trials are for people that don't have the genetic condition. It would work to regrow them but you might just lose them again because of it.What about genetic causes? Would FX-322 work for that? Alport syndrome for example.
Or this:I wish the timeline were like this:
2019 - Phase 2
2020 - Phase 3
2021 - Available
Do you mean like genetic? Or progressive?
Is there any chance that they will do it so fast? I'm afraid they'll choose the slow way.Or this:
2018 phase 1/2, it works! Skip to an open phase 3 in 2019 and allow people to have it.
Well they are a startup corporation and the economics of that dictate that they want to keep initial costs low and get to market ASAP.Is there any chance that they will do it so fast? I'm afraid they'll choose the slow way.
Sorry JohnAdams. I agree with @annV, although I'd put it a little less bluntly.After this trial they may know they have a good thing and want people like us to demand it.
yes, restoring hearing in rodents and replicating the process in vitro in human tissue is a fantasy. so glad you agree with annv, an old woman that goes to disease support forums and insults people that believe in God.Sorry JohnAdams. I agree with @annV, although I'd put it a little less bluntly.
It's all just fantasy and wishful thinking. If it happens - and we all hope it does - it will happen in its own time.
I swear sometimes you talk to people and realise they're in the stone age.yes, restoring hearing in rodents and replicating the process in vitro in human tissue is a fantasy. so glad you agree with annv, an old woman that goes to disease support forums and insults people that believe in God.
I never said I know it works ive just said this is the best hope we have and we should be focused on this and IF IF IF IF IF IF IF IF IF IF IF IF IT WORKS then we should be advocating that the FDA cut red tape on it. if you disagree then you're just something special.
https://www.bloomberg.com/news/audi...iness-papa-ginos-rhode-island-elections-radio
Nothing big, Lucchino talking to Bloomberg.
I didn't get a chance to listen to it, I'll check it out when I get home after work.
I'm not going to say anything, in December we will talk again.
Starts at 47:20 mark.https://www.bloomberg.com/news/audi...iness-papa-ginos-rhode-island-elections-radio
Nothing big, Lucchino talking to Bloomberg.
Frequency Therapeutics finishes their trial.What's in December?
Results of phase 1.5 will be reported.What's in December?
I think she refers to the results of phase 1/2.What's in December?
The current trial finishes in December. If it works and say 15 out 16 show improvement then it's pretty much a done deal. (Yes, I have my hopes up...)What's in December?
What's in December?
I was just about to post this link, but here are a few things Lucchino mentioned:
- Frequency Therapeutics won't be looking at the data from this current trial until early next calendar year
- Lucchino made a offhand statement that FX-322 might be able to help those with severe hearing loss, but backtracks by stating the focus is on individuals who have lesser degrees of hearing loss
- Based on the data reviewed early next year, Frequency Therapeutics will try to go for the designated breakthrough status with the FDA to fast track this drug if they are seeing the results they are looking for in the current study.
Does this mean it'll only help those with mild and severe hearing loss? So any other type of hearing loss won't benefit? What about moderate hearing loss?I was just about to post this link, but here are a few things Lucchino mentioned:
- Frequency Therapeutics won't be looking at the data from this current trial until early next calendar year
- Lucchino made a offhand statement that FX-322 might be able to help those with severe hearing loss, but backtracks by stating the focus is on individuals who have lesser degrees of hearing loss
- Based on the data reviewed early next year, Frequency Therapeutics will try to go for the designated breakthrough status with the FDA to fast track this drug if they are seeing the results they are looking for in the current study.